$ Value
$103K
Shares
6,797
Price
$15
Filed
May 15
Insider
Name
Cobb Stuart
Title
Chief Scientific Officer
CIK
0001994301
Roles
Transaction Details
Transaction Date
2025-05-14
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
20,794
Footnotes
The transactions reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on February 6, 2025. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.78 to $15.75. The reporting person undertakes to provide Neurogene Inc. (the "Company"), any securityholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Filing Info
Cobb Stuart's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-13 | NGNE | ▼ | $81K |
| 2026-03-13 | NGNE | ▼ | $57K |
| 2026-03-13 | NGNE | ▼ | $3K |
| 2026-02-20 | NGNE | A | $0 |
| 2025-05-14 | NGNE | ▼ | $103K |
Other Insiders at NGNE (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BAFFI ROBERT | — | — | 2026-02-20 |
| PALEKAR ROHAN | — | — | 2026-02-20 |
|
Cvijic Christine Mikail
President and CFO
|
— | $260K | 2026-03-26 |
|
McMinn Rachel
Chief Executive Officer
|
— | $74K | 2026-03-26 |
| Noonberg Sarah B. | — | — | 2026-02-20 |
| Freedland Cory S. | — | — | 2026-02-20 |
|
Jordan Julie
Chief Medical Officer
|
— | $18K | 2026-03-26 |
|
Cobb Stuart
Chief Scientific Officer
|
— | $141K | 2026-03-13 |
| Woods Keith | — | — | 2026-02-20 |